Hem › Prostatacancer › Vermont › Burlington
Kliniska studier för Prostatacancer i Burlington, VT
4 studier för Prostatacancer söker deltagare vid platser i och runt Burlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekryterarFas 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekryterarFas 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
RekryterarFas 2
- University of Vermont Medical Center, Burlington
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekryterarFas 3
- University of Vermont Medical Center, Burlington
Prostatacancer-studier i andra städer
- New York City, NY103 studier
- Houston, TX76 studier
- Los Angeles, CA61 studier
- Boston, MA59 studier
- St. Louis, MO46 studier
- Chicago, IL45 studier
- San Francisco, CA45 studier
- Philadelphia, PA44 studier
- Baltimore, MD43 studier
- Nashville, TN42 studier
- Seattle, WA42 studier
- Washington, DC38 studier
Andra studier i Burlington
- Hjärtsvikt8 studier
- Akut myeloid leukemi7 studier
- Cancer (alla typer)6 studier
- KOL5 studier
- Bröstcancer5 studier
- Parkinsons sjukdom4 studier
- Icke-småcellig lungcancer4 studier
- Cystisk fibros4 studier
- Lungsjukdomar4 studier
- Leukemi4 studier
- Hjärt-kärlsjukdom4 studier
- Metastaserande cancer4 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.